Buyers Urge 3rd Circ. To Reopen Effexor Pay-For-Delay Suit

Drug buyers on Thursday urged the Third Circuit to revive antitrust claims against Wyeth and Teva over an alleged bribe to delay a generic version of the antidepressant Effexor XR, arguing...

Already a subscriber? Click here to view full article